ibr 560 Pill - orange oval, 19mm
Generic Name: ibrutinib
Pill with imprint ibr 560 is Orange, Oval and has been identified as Imbruvica 560 mg. It is supplied by Pharmacyclics, Inc.
Imbruvica is used in the treatment of Chronic Lymphocytic Leukemia; Waldenström Macroglobulinemia; Graft-versus-host disease and belongs to the drug class BTK inhibitors. There is positive evidence of human fetal risk during pregnancy. Imbruvica 560 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ibr 560
Imbruvica
- Generic Name
- ibrutinib
- Imprint
- ibr 560
- Strength
- 560 mg
- Color
- Orange
- Size
- 19.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- BTK inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pharmacyclics, Inc.
- National Drug Code (NDC)
- 57962-0560 (Discontinued)
More about Imbruvica (ibrutinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (59)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: BTK inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
